FIERRO, Maria Teresa
 Distribuzione geografica
Continente #
NA - Nord America 2533
EU - Europa 1813
AS - Asia 1049
OC - Oceania 100
SA - Sud America 98
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5632
Nazione #
US - Stati Uniti d'America 2388
IT - Italia 457
CN - Cina 415
DE - Germania 305
GB - Regno Unito 228
JP - Giappone 178
FR - Francia 168
ES - Italia 132
CA - Canada 117
IN - India 102
AU - Australia 84
KR - Corea 81
NL - Olanda 66
UA - Ucraina 59
PL - Polonia 49
HK - Hong Kong 45
TR - Turchia 44
BR - Brasile 43
CH - Svizzera 36
VN - Vietnam 33
RO - Romania 31
IE - Irlanda 29
AT - Austria 27
RU - Federazione Russa 27
DK - Danimarca 25
TW - Taiwan 24
MX - Messico 23
CZ - Repubblica Ceca 22
SE - Svezia 21
PT - Portogallo 20
GR - Grecia 18
ZA - Sudafrica 18
TH - Thailandia 17
BE - Belgio 16
CO - Colombia 16
NZ - Nuova Zelanda 16
AR - Argentina 15
MO - Macao, regione amministrativa speciale della Cina 15
NO - Norvegia 15
CL - Cile 14
MY - Malesia 14
IR - Iran 13
EG - Egitto 11
ID - Indonesia 11
PH - Filippine 11
HU - Ungheria 10
FI - Finlandia 8
IL - Israele 8
LT - Lituania 8
SG - Singapore 8
HR - Croazia 7
BG - Bulgaria 6
CY - Cipro 6
PK - Pakistan 6
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 6
SI - Slovenia 5
AL - Albania 4
EC - Ecuador 4
BZ - Belize 3
EE - Estonia 3
LB - Libano 3
PE - Perù 3
GH - Ghana 2
MA - Marocco 2
MK - Macedonia 2
QA - Qatar 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
DZ - Algeria 1
EU - Europa 1
GY - Guiana 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 5632
Città #
Fairfield 214
Houston 190
Ann Arbor 143
Torino 133
Beijing 117
Ashburn 108
Buffalo 100
Woodbridge 95
Seattle 93
Santa Cruz 88
Cambridge 83
Wilmington 64
Shanghai 49
London 40
University Park 40
Ottawa 39
Tokyo 39
Wuhan 36
Guangzhou 34
Chicago 30
Mountain View 30
Duncan 28
New York 25
Dong Ket 22
Las Vegas 22
Warsaw 22
Milan 21
Columbus 20
Hangzhou 20
Taipei 20
Rochester 19
San Diego 19
Barcelona 18
Paris 18
Göttingen 17
Pisa 17
Salt Lake City 17
Bengaluru 16
Dublin 16
Lake Forest 15
Los Angeles 15
Nanjing 15
Madrid 14
Philadelphia 14
Saint Louis 14
Berlin 13
Bogotá 13
Changsha 13
Phoenix 13
Sydney 13
Toronto 13
Istanbul 12
Park Forest 12
Wyckoff 12
Atlanta 11
Central 11
Central District 11
Fleming Island 11
Seoul 11
Shenyang 11
Hazelwood 10
Muizenberg 10
Nürnberg 10
Portland 10
Saint-herblain 10
Vancouver 10
Athens 9
Bangkok 9
Boardman 9
Des Moines 9
Hyderabad 9
Jakarta 9
Melbourne 9
Muenster 9
São Paulo 9
Turin 9
Aarhus 8
Ankara 8
Bologna 8
Chengdu 8
Clearwater 8
Kansas City 8
Munich 8
Singapore 8
Toowong 8
Vienna 8
Austin 7
Dallas 7
Denver 7
San Francisco 7
Santiago 7
Amsterdam 6
Brusperk 6
Buenos Aires 6
Dearborn 6
Essen 6
Frankfurt Am Main 6
Haywards Heath 6
Jacksonville 6
Macau 6
Totale 2708
Nome #
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial, file e27ce42f-1e56-2581-e053-d805fe0acbaa 2190
Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis, file e27ce42b-89db-2581-e053-d805fe0acbaa 435
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives, file e27ce428-b16f-2581-e053-d805fe0acbaa 290
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis., file e27ce42b-917f-2581-e053-d805fe0acbaa 257
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients., file e27ce426-c42d-2581-e053-d805fe0acbaa 254
Atopic dermatitis in a phenylketonuric untreated patient, file e27ce426-ecb1-2581-e053-d805fe0acbaa 247
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years., file e27ce427-0c20-2581-e053-d805fe0acbaa 238
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody, file e27ce42c-bad0-2581-e053-d805fe0acbaa 171
Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality, file e27ce42b-69f3-2581-e053-d805fe0acbaa 133
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers., file e27ce42b-c369-2581-e053-d805fe0acbaa 126
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up., file e27ce427-0d50-2581-e053-d805fe0acbaa 110
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study, file e27ce426-c431-2581-e053-d805fe0acbaa 101
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood, file e27ce426-aec9-2581-e053-d805fe0acbaa 91
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients., file e27ce426-fa98-2581-e053-d805fe0acbaa 91
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease., file e27ce426-c640-2581-e053-d805fe0acbaa 84
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium, file e27ce431-94e8-2581-e053-d805fe0acbaa 78
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk, file e27ce42e-4440-2581-e053-d805fe0acbaa 77
Nutritional interventions for patients with melanoma: From prevention to therapy—an update, file e27ce434-1486-2581-e053-d805fe0acbaa 74
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172), file e27ce433-fac8-2581-e053-d805fe0acbaa 73
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas, file e27ce428-b1d8-2581-e053-d805fe0acbaa 72
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases., file e27ce428-fabc-2581-e053-d805fe0acbaa 65
Prognostic differences across sexes in melanoma patients: What has changed from the past?, file e27ce428-b16d-2581-e053-d805fe0acbaa 58
Immunotherapy in transplanted patients: A special population that can no longer be ignored, file e27ce432-2906-2581-e053-d805fe0acbaa 55
HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects., file e27ce428-a7d6-2581-e053-d805fe0acbaa 52
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group, file e27ce428-ada6-2581-e053-d805fe0acbaa 50
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review, file e27ce431-ef83-2581-e053-d805fe0acbaa 41
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work], file e27ce426-e79d-2581-e053-d805fe0acbaa 40
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp, file e27ce426-c57b-2581-e053-d805fe0acbaa 36
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?, file e27ce427-0238-2581-e053-d805fe0acbaa 36
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome, file e27ce428-f0f1-2581-e053-d805fe0acbaa 32
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature., file e27ce42a-34b0-2581-e053-d805fe0acbaa 26
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work], file e27ce427-5aea-2581-e053-d805fe0acbaa 23
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis, file e27ce427-ae67-2581-e053-d805fe0acbaa 17
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients, file e27ce435-7505-2581-e053-d805fe0acbaa 14
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System, file e27ce435-06dd-2581-e053-d805fe0acbaa 12
Role of interferon in melanoma: old hopes and new perspectives, file e27ce42d-3bfb-2581-e053-d805fe0acbaa 10
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome, file beb7d7df-91c3-486a-86de-6a512675346f 9
Efficacy of electrochemotherapy for eruptive legs keratoacanthomas, file e27ce42b-b8d5-2581-e053-d805fe0acbaa 8
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL), file e27ce433-a04c-2581-e053-d805fe0acbaa 7
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work], file e27ce426-d796-2581-e053-d805fe0acbaa 6
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?, file e27ce427-0c79-2581-e053-d805fe0acbaa 6
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome, file e27ce435-034f-2581-e053-d805fe0acbaa 6
Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients, file e27ce42f-e9bb-2581-e053-d805fe0acbaa 5
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study, file e27ce435-2f78-2581-e053-d805fe0acbaa 5
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial, file e27ce42e-72f4-2581-e053-d805fe0acbaa 4
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work], file e27ce426-e79c-2581-e053-d805fe0acbaa 3
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up., file e27ce427-0d4f-2581-e053-d805fe0acbaa 3
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas, file e27ce428-a7bd-2581-e053-d805fe0acbaa 3
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL), file e27ce42a-f8b8-2581-e053-d805fe0acbaa 3
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL), file e27ce432-46f2-2581-e053-d805fe0acbaa 3
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial, file e27ce432-4d85-2581-e053-d805fe0acbaa 3
Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption., file e27ce426-ca72-2581-e053-d805fe0acbaa 2
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study, file e27ce426-d928-2581-e053-d805fe0acbaa 2
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature., file e27ce426-fa96-2581-e053-d805fe0acbaa 2
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases., file e27ce427-632a-2581-e053-d805fe0acbaa 2
Prognostic differences across sexes in melanoma patients: What has changed from the past?, file e27ce428-a570-2581-e053-d805fe0acbaa 2
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients., file e27ce426-c42e-2581-e053-d805fe0acbaa 1
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome., file e27ce427-61e9-2581-e053-d805fe0acbaa 1
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis, file e27ce427-89f6-2581-e053-d805fe0acbaa 1
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group, file e27ce427-f3ea-2581-e053-d805fe0acbaa 1
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome, file e27ce428-a7ce-2581-e053-d805fe0acbaa 1
HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects., file e27ce428-afce-2581-e053-d805fe0acbaa 1
Prognostic role of maspin expression in melanoma: Probably far from clinical use, file e27ce42b-c7c0-2581-e053-d805fe0acbaa 1
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients, file e27ce432-4d83-2581-e053-d805fe0acbaa 1
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172), file e27ce432-4d86-2581-e053-d805fe0acbaa 1
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up., file e27ce432-5820-2581-e053-d805fe0acbaa 1
Treatment of metastatic melanoma: a multidisciplinary approach, file e27ce432-60b3-2581-e053-d805fe0acbaa 1
Totale 5854
Categoria #
all - tutte 6757
article - articoli 0
book - libri 0
conference - conferenze 24
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018115 0000 00 022 24291822
2018/2019466 22272622 1817 1835 45559487
2019/2020838 59464389 4549 6987 95909076
2020/20211368 1541078554 127121 99154 12913195112
2021/20221614 144122110214 19487 11993 12591189126
2022/2023937 11489183157 137111 1424 0000
Totale 5854